American Century Companies Inc Alkermes Plc. Transaction History
American Century Companies Inc
- $168 Billion
- Q4 2024
A detailed history of American Century Companies Inc transactions in Alkermes Plc. stock. As of the latest transaction made, American Century Companies Inc holds 3,450,707 shares of ALKS stock, worth $124 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,450,707
Previous 3,240,967
6.47%
Holding current value
$124 Million
Previous $90.7 Million
9.4%
% of portfolio
0.06%
Previous 0.05%
Shares
14 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$664 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$440 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$316 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$271 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.9B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...